ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP issued a solicitation reminding ARDX investors of a pending securities fraud class action with a lead plaintiff deadline of November 16, 2026. The complaint alleges Ardelyx made misleading statements regarding reimbursement barriers for XPHOZAH and IBSRELA, including prior-authorization and step-edit requirements that delayed new-patient starts and hurt commercial performance during the class period of January 13, 2025 to August 6, 2026.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.